Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
Mallinckrodt
Merck
Moodys
Dow

Last Updated: November 15, 2019

DrugPatentWatch Database Preview

BUMETANIDE Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Bumetanide patents expire, and what generic alternatives are available?

Bumetanide is a drug marketed by Athenex Inc, Hospira, Teva Parenteral, West-ward Pharms Int, Amneal Pharms Co, Heritage Pharma, Sandoz, Upsher Smith Labs, and Zydus Pharms. and is included in ten NDAs.

The generic ingredient in BUMETANIDE is bumetanide. There are six drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the bumetanide profile page.

Drug patent expirations by year for BUMETANIDE
Drug Prices for BUMETANIDE

See drug prices for BUMETANIDE

Drug Sales Revenue Trends for BUMETANIDE

See drug sales revenues for BUMETANIDE

Recent Clinical Trials for BUMETANIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Hospital General de México Dr. Eduardo LiceagaPhase 4
B&A TherapeuticsPhase 2
Centro en Insuficiencia Cardiaca, MexicoPhase 4

See all BUMETANIDE clinical trials

Pharmacology for BUMETANIDE
Medical Subject Heading (MeSH) Categories for BUMETANIDE
Synonyms for BUMETANIDE
0Y2S3XUQ5H
28395-03-1
28395-03-1,28434-74-4(sodiumsalt)
3-(aminosulfonyl)-5-(butylamino)-4-(phenyloxy)benzoic acid
3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid
3-(butylamino)-4-phenoxy-5-sulfamoyl-benzoic acid
3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid
3-butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid
3-butylamino-4-phenoxy-5-sulfamoyl-benzoic acid
3-butylamino-4-phenoxy-5-sulfamoylbenzoic acid
3-butylamino-4-phenoxy-5-sulphamyl-benzoic acid
3-n-butylamino-4-phenoxy-5-sulfamyl-benzoic acid
3-n-butylamino-4-phenoxy-5-sulphamyl-benzoic acid
395B031
A819434
AB00052253
AB00052253_17
AB00052253_18
AB00052253-15
AB00052253-16
AB0012138
AB2000031
AC-8115
AC1L1DR5
AJ-45693
AKOS015896600
AN-8345
ANW-45473
Aquazone
B 3023
BC208864
BDBM25903
Benzoic acid, 3-(aminosulfonyl)-5-(butylamino)-4-phenoxy-
BENZOIC ACID, 3-(BUTYLAMINO)-4-PHENOXY-5-SULFAMOYL-
Bio1_000421
Bio1_000910
Bio1_001399
Bio2_000228
Bio2_000708
BPBio1_000168
BRD-K38197229-001-06-7
BRD-K38197229-001-17-4
BRN 2185351
BSPBio_000152
BSPBio_001508
BSPBio_003061
Bufenox
Bumetanida
Bumetanida [INN-Spanish]
Bumetanide (JP17/USP/INN)
Bumetanide (Ro 10-6338)
Bumetanide [USAN:BAN:INN:JAN]
Bumetanide [USAN:USP:INN:BAN:JAN]
Bumetanide, >=98%
Bumetanide, British Pharmacopoeia (BP) Reference Standard
Bumetanide, European Pharmacopoeia (EP) Reference Standard
Bumetanide, United States Pharmacopeia (USP) Reference Standard
Bumetanidum
Bumetanidum [INN-Latin]
Bumethanide
Bumex
Bumex (TN)
Burine
Burinex
Butinat
C17H20N2O5S
Cambiex
CAS-28395-03-1
CCG-40125
CHEBI:3213
CHEMBL1072
cid_2471
CPD000058418
CS-1821
CTK8B4560
D00247
DB00887
Diurama
DivK1c_000034
DSSTox_CID_2699
DSSTox_GSID_22699
DSSTox_RID_76695
DTXSID5022699
EINECS 249-004-6
EU-0100162
Fontego
Fordiuran
FT-0623285
GTPL4837
HMS1361L10
HMS1568H14
HMS1791L10
HMS1921B20
HMS1989L10
HMS2089P13
HMS2092N03
HMS2095H14
HMS2230P15
HMS3259O08
HMS3260B05
HMS3374E02
HMS3402L10
HMS3654B13
HMS3712H14
HMS500B16
HY-17468
I06-2277
IDI1_000034
IDI1_033978
J-017055
J10080
KB-48483
KBio1_000034
KBio2_000228
KBio2_001797
KBio2_002796
KBio2_004365
KBio2_005364
KBio2_006933
KBio3_000455
KBio3_000456
KBio3_002561
KBioGR_000228
KBioGR_000439
KBioSS_000228
KBioSS_001797
KS-00000XN2
KS-5211
Lixil
Lixil-Leo
Lopac-B-3023
Lopac0_000162
LP00162
LS-36330
Lunetoron
MAEIEVLCKWDQJH-UHFFFAOYSA-N
MCULE-6802013568
MFCD00078949
MLS000028457
MLS001148265
MolPort-003-666-390
NC00550
NCGC00015149-01
NCGC00015149-02
NCGC00015149-03
NCGC00015149-04
NCGC00015149-05
NCGC00015149-06
NCGC00015149-07
NCGC00015149-08
NCGC00015149-09
NCGC00015149-10
NCGC00015149-11
NCGC00015149-12
NCGC00015149-13
NCGC00015149-15
NCGC00015149-16
NCGC00022072-03
NCGC00022072-04
NCGC00022072-05
NCGC00022072-06
NCGC00022072-07
NCGC00022072-08
NCGC00260847-01
NE48825
NINDS_000034
NSC-758145
NSC758145
Opera_ID_1734
PF 1593
PF-1593
Pharmakon1600-01502004
Prestwick_679
Prestwick0_000276
Prestwick1_000276
Prestwick2_000276
Prestwick3_000276
Ro 10-6338
Ro-106338
s1287
SAM002564195
SBI-0050150.P003
SC-12128
SCHEMBL27525
Segurex
SMP1_000049
SMR000058418
SPBio_000980
SPBio_002371
Spectrum_001317
SPECTRUM1502004
Spectrum2_001050
Spectrum3_001481
Spectrum4_000030
Spectrum5_001212
SR-01000003062
SR-01000003062-2
SR-01000003062-4
SR-01000003062-7
ST2404803
ST51014910
SW196834-3
TC-134218
Tox21_110088
Tox21_110088_1
Tox21_500162
UNII-0Y2S3XUQ5H
Yurinex
Z1550648769
ZINC3813061

US Patents and Regulatory Information for BUMETANIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Athenex Inc BUMETANIDE bumetanide INJECTABLE;INJECTION 074441-001 Jan 27, 1995 DISCN No No   Start Trial   Start Trial   Start Trial
Zydus Pharms BUMETANIDE bumetanide TABLET;ORAL 202900-001 Apr 30, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Amneal Pharms Co BUMETANIDE bumetanide TABLET;ORAL 209724-002 Oct 18, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Teva Parenteral BUMETANIDE bumetanide INJECTABLE;INJECTION 074613-001 Nov 18, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
Sandoz BUMETANIDE bumetanide TABLET;ORAL 074700-001 Nov 21, 1996 AB RX No No   Start Trial   Start Trial   Start Trial
Zydus Pharms BUMETANIDE bumetanide TABLET;ORAL 202900-003 Apr 30, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Harvard Business School
Dow
Colorcon
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.